Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for GDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 647.60M
March 31, 2026 621.99M
December 31, 2025 616.26M
September 30, 2025 600.71M
June 30, 2025 643.03M
March 31, 2025 654.35M
December 31, 2024 724.66M
September 30, 2024 696.43M
June 30, 2024 669.40M
March 31, 2024 631.07M
December 31, 2023 761.96M
September 30, 2023 881.27M
June 30, 2023 895.37M
March 31, 2023 827.47M
Date Value
December 31, 2022 814.83M
September 30, 2022 788.40M
June 30, 2022 817.94M
March 31, 2022 786.51M
December 31, 2021 831.68M
September 30, 2021 846.40M
June 30, 2021 824.39M
March 31, 2021 749.06M
December 31, 2020 711.36M
September 30, 2020 756.41M
June 30, 2020 -289.73M
March 31, 2020
December 31, 2019 -350.57M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 7.053M
SCWorx Corp. 6.932M
Health Catalyst, Inc. 100.83M
Claritev Corp. -294.56M
iSpecimen, Inc. 1.736M

Shareholders Equity (Quarterly) Related Metrics